Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994

The PCPNDT Act, 1994 has come under renewed focus due to the rising burden of rural cancers and rapid advancements in portable ultrasonography.

About the PCPNDT Act, 1994

• The Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 was enacted to prevent female foeticide and arrest the declining Child Sex Ratio (CSR) in India.

• The Act regulates the use of prenatal diagnostic technologies and strictly prohibits their misuse for sex selection or sex determination.

• The Act was substantially amended in 2003 to extend its scope beyond prenatal diagnosis and include pre-conception sex selection technologies, making any disclosure of the sex of the foetus completely illegal.

Objectives of the Act

Prevent Female Foeticide

The primary objective of the Act is to eliminate sex-selective abortions by prohibiting the misuse of diagnostic technologies.

Protect the Child Sex Ratio

The legislation seeks to improve the Child Sex Ratio (CSR) by discouraging gender-biased practices before birth.

Regulate Diagnostic Technologies

It establishes a legal framework for the registration, monitoring, and regulation of ultrasound clinics, genetic laboratories, and diagnostic centres.

Major Provisions of the PCPNDT Act

Mandatory Registration of Clinics

Every genetic counselling centre, genetic laboratory, genetic clinic, ultrasound clinic, and imaging centre must obtain mandatory registration from the State Appropriate Authority before purchasing or operating any ultrasound equipment.

No unregistered institution is permitted to possess or use ultrasound machines.

Strict Control over Ultrasound Equipment

The Act imposes stringent restrictions on the movement of ultrasound machines.

Once installed at a registered facility, an ultrasound machine cannot be shifted without prior approval. Unauthorized movement constitutes a serious criminal offence, punishable with a minimum three months of non-bailable imprisonment.

Complete Ban on Sex Determination

The Act prohibits the communication or disclosure of the sex of the foetus under all circumstances, irrespective of whether the parents request such information.

Any attempt to determine or reveal the foetal sex attracts severe criminal penalties.

Maintenance of Detailed Records

Every registered clinic must maintain complete documentation, particularly Form F, which records medical indications for conducting prenatal diagnostic procedures.

The form also contains a declaration by the pregnant woman affirming that she does not wish to know the sex of the foetus.

Prohibition of Advertisements

The Act completely prohibits advertisements promoting pre-conception or prenatal sex determination services.

Any individual or institution advertising such services is liable for prosecution.

Institutional Monitoring Mechanism

The Act establishes multiple supervisory bodies to ensure effective implementation.

These include the Central Supervisory Board, State Supervisory Boards, and Appropriate Authorities, which oversee registration, inspections, investigations, and enforcement.

Stringent Penalties

Violations under the Act are treated as cognizable, non-bailable, and non-compoundable offences.

Punishments include:

• Imprisonment up to 3 years

• Monetary fines

• Suspension or cancellation of the medical practitioner's registration

Impact of the PCPNDT Act

Improvement in Sex Ratio at Birth

The Act has contributed to a gradual improvement in India's Sex Ratio at Birth (SRB).

According to NFHS-5, the national SRB improved to 929 females per 1,000 males, compared to 919 females per 1,000 males in NFHS-4.

Reduction in Commercial Sex Determination

Strict enforcement, particularly following the CEHAT v. Union of India (2001) Supreme Court judgment, significantly reduced the open commercialization of sex-determination clinics across the country.

Emergence of Underground Networks

The stringent regulatory framework has also led to unintended consequences.

Illegal operators have increasingly relied on unregistered portable ultrasound machines and informal networks to evade government surveillance.

Behavioural Changes among Families

In certain regions, the inability to access sex-selective abortions has resulted in higher fertility rates, as families continue having children until the birth of a male child.

This has sometimes caused resource dilution and reduced investment in the health and education of daughters.

Need for Reform in the PCPNDT Act

Technological Obsolescence

The Act treats all ultrasound machines uniformly, regardless of their technological capabilities.

However, modern high-frequency linear probes used for community-based breast cancer screening are technically incapable of determining the sex of a foetus.

Despite this limitation, they remain subject to the same movement restrictions, reducing access to life-saving diagnostics in rural India.

Rise of Advanced Genomic Technologies

Technological advancements such as Non-Invasive Prenatal Testing (NIPT) now enable foetal sex determination through a simple maternal blood sample, without using ultrasound.

The current legal framework remains largely focused on ultrasound machines and does not adequately regulate these emerging technologies.

Criminalisation of Minor Clerical Errors

Medical professionals have expressed concern that minor mistakes in maintaining Form F are often treated on par with actual offences involving sex determination.

Although the Federation of Obstetric and Gynaecological Societies of India (FOGSI) v. Union of India (2019) judgment upheld strict compliance requirements, doctors argue that excessive criminal liability discourages many radiologists from offering essential maternal healthcare services.

Integration of Artificial Intelligence

Emerging AI-enabled ultrasound systems can be designed to generate diagnostic reports for specific diseases while technologically preventing visualization or disclosure of foetal sex.

Incorporating such safeguards into the regulatory framework could simultaneously strengthen healthcare delivery and prevent misuse.

Way Forward

• India needs to modernise the PCPNDT Act by distinguishing between ultrasound devices capable of prenatal sex determination and those used exclusively for non-obstetric medical purposes such as breast cancer screening.

• The law should also develop a comprehensive regulatory framework for NIPT and other emerging genomic technologies.

• Greater emphasis should be placed on risk-based regulation, technological safeguards, AI-enabled monitoring, and proportionate penalties for procedural lapses, while continuing strict action against deliberate sex determination.

• Balancing gender justice with accessible healthcare will ensure that the Act remains effective against female foeticide without restricting the delivery of critical diagnostic services in underserved regions.